Nephro-Urology Monthly

Published by: Kowsar

Longitudinal Assessment of Serum Creatinine Levels on Graft Survival After Renal Transplantation: Joint Modeling Approach

Elham Maraghi 1 , Abbas Rahimi Foroushani 1 , Shima Younespour 1 , Zohreh Rostami 2 , Behzad Einollahi 2 , Mohammad Reza Eshraghian 1 , * , Mohammad Reza Akhoond 3 and Kazem Mohammad 1
Authors Information
1 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
2 Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Department of Statistics, Mathematical Science and Computer Faculty, Shahid Chamran University, Ahvaz, IR Iran
Article information
  • Nephro-Urology Monthly: July 01, 2016, 8 (4); e37666
  • Published Online: June 7, 2016
  • Article Type: Research Article
  • Received: March 28, 2016
  • Revised: April 13, 2016
  • Accepted: May 28, 2016
  • DOI: 10.5812/numonthly.37666

To Cite: Maraghi E, Rahimi Foroushani A, Younespour S, Rostami Z, Einollahi B, et al. Longitudinal Assessment of Serum Creatinine Levels on Graft Survival After Renal Transplantation: Joint Modeling Approach, Nephro-Urol Mon. 2016 ; 8(4):e37666. doi: 10.5812/numonthly.37666.

Abstract
Copyright © 2016, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Daugirdas JT, Blake PG, Ing TS. Handbook of dialysis. 2015;
  • 2. Hassanien AA, Al-Shaikh F, Vamos EP, Yadegarfar G, Majeed A. Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review. JRSM Short Rep. 2012; 3(6): 38[DOI][PubMed]
  • 3. Mousavi SS, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl. 2014; 25(3): 697-702[PubMed]
  • 4. Beladi Mousavi SS, Hayati F, Valavi E, Rekabi F, Mousavi MB. Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis. Saudi J Kidney Dis Transpl. 2015; 26(2): 392-7[PubMed]
  • 5. Mehrotra R, Khawar O, Duong U, Fried L, Norris K, Nissenson A, et al. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. Am J Kidney Dis. 2009; 54(2): 289-98[DOI][PubMed]
  • 6. Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, et al. Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int. 2007; 72(8): 1023-8[DOI][PubMed]
  • 7. Mirzaee M, Azmandian J, Zeraati H, Mahmoodi M, Mohammad K, Etminan A, et al. Short-term and long-term survival of kidney allograft: cure model analysis. Iran J Kidney Dis. 2014; 8(3): 225-30[PubMed]
  • 8. Salehipour M, Salahi H, Jalaeian H, Bahador A, Nikeghbalian S, Barzideh E, et al. Vascular complications following 1500 consecutive living and cadaveric donor renal transplantations: a single center study. Saudi J Kidney Dis Transpl. 2009; 20(4): 570-2[PubMed]
  • 9. Salesi M, Rostami Z, Rahimi Foroushani A, Mehrazmay AR, Mohammadi J, Einollahi B, et al. Chronic graft loss and death in patients with post-transplant malignancy in living kidney transplantation: a competing risk analysis. Nephrourol Mon. 2014; 6(2): 14302[DOI][PubMed]
  • 10. Hassan ANS. Patient And Allograft Survival After Transplantation With A Living Donor Kidney: 14 Years Experience. East Cent Afr J Surg. 2007; 8(1): 19-24
  • 11. Arend SM, Mallat MJ, Westendorp RJ, Van Der Woude FJ, Van Es LA. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant. 1997; 12(8): 1672-9
  • 12. Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant. 2001; 16(8): 1545-9[PubMed]
  • 13. de Andrade LG, Abrao JM, Carvalho MF. Anemia at one year is an independent risk factor of graft survival. Int Urol Nephrol. 2012; 44(1): 263-8[DOI][PubMed]
  • 14. Einollahi B. Iranian experience with the non-related renal transplantation. Saudi J Kidney Dis Transpl. 2004; 15(4): 421-8[PubMed]
  • 15. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000; 342(9): 605-12[DOI][PubMed]
  • 16. Kainz A, Wilflingseder J, Fugger R, Kramar R, Oberbauer R. Hemoglobin variability after renal transplantation is associated with mortality. Transpl Int. 2012; 25(3): 323-7[DOI][PubMed]
  • 17. Kamar N, Rostaing L, Ignace S, Villar E. Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transplant. 2012; 26(3): 461-9[DOI][PubMed]
  • 18. Merion RM, White DJ, Thiru S, Evans DB, Calne RY. Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med. 1984; 310(3): 148-54[DOI][PubMed]
  • 19. Smedbraten YV, Sagedal S, Leivestad T, Mjoen G, Osnes K, Rollag H, et al. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival. Clin Transplant. 2014; 28(1): 120-6[DOI][PubMed]
  • 20. Little RJA, Rubin DB. Statistical analysis with missing data. 2002;
  • 21. Prentice RL. Covariate measurement errors and parameter estimation in a failure time regression model. Biometrika. 1982; 69(2): 12
  • 22. Ratcliffe SJ, Guo W, Ten Have TR. Joint modeling of longitudinal and survival data via a common frailty. Biometrics. 2004; 60(4): 892-9[DOI][PubMed]
  • 23. Andrinopoulou ER, Rizopoulos D, Jin R, Bogers AJ, Lesaffre E, Takkenberg JJ. An introduction to mixed models and joint modeling: analysis of valve function over time. Ann Thorac Surg. 2012; 93(6): 1765-72[DOI][PubMed]
  • 24. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. 2011; 360
  • 25. Rizopoulos D. Joint models for longitudinal and time-to-event data: With applications in R. 2012;
  • 26. Rizopoulos D. JM: An R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw. 2010; 35(9): 1-33
  • 27. Aramesh K. Iran’s Experience on Living and Brain-Dead Organ Donation: A Critical Review. Organ Transplantation in Times of Donor Shortage. 2016; : 285-92
  • 28. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K. Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. AmJ Kidney Dis. 2012; 59(1Suppl1)
  • 29. Jaffa MA, Gebregziabher M, Jaffa AA. Analysis of multivariate longitudinal kidney function outcomes using generalized linear mixed models. J Transl Med. 2015; 13: 192[DOI][PubMed]
  • 30. Asar O, Ritchie J, Kalra PA, Diggle PJ. Joint modelling of repeated measurement and time-to-event data: an introductory tutorial. Int J Epidemiol. 2015; 44(1): 334-44[DOI][PubMed]
  • 31. Debout A, Foucher Y, Trebern-Launay K, Legendre C, Kreis H, Mourad G, et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int. 2015; 87(2): 343-9[DOI][PubMed]
  • 32. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002; 346(8): 580-90[DOI][PubMed]
  • 33. Rizopoulos D, Ghosh P. A Bayesian semiparametric multivariate joint model for multiple longitudinal outcomes and a time-to-event. Stat Med. 2011; 30(12): 1366-80[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments